Washington Post
Most people dying of the coronavirus are 65 and older, my colleagues Ariana Eunjung Cha and Dan Keating report. While much of our society has moved on from masking, vaccine mandates and other mitigation efforts, older people and those with compromised immune systems remain at elevated risk from the virus.
According to Cha and Keating, people in this age cohort are dying at “roughly two to three times the rate at which people die of the flu.”
“Some epidemiologists and demographers predict the trend of older, sicker and poorer people dying at disproportionate rates will continue, raising hard questions about the trade-offs Americans are making in pursuit of normalcy — and at whose expense,” Cha and Keating write.
The Food and Drug Administration announced Wednesday it is pulling emergency use authorization for the monoclonal antibody treatment bebtelovimab because “it is not expected to neutralize Omicron subvariants BQ. 1 and BQ. 1.1.,” the agency said in a statement.